The Physician Burnout Crisis, with Sue Padernacht, EDd, PCC


The first Lungcast of 2024 touches on one of the most pressing issues in medicine: burnout, with an organizational expert.

Episode Highlights

0:15 Introducing Sue Padernacht, EDd, PCC
1:16 The definition of burnout
3:53 The history of burnout
7:45 Differences between stress and burnout
14:34 Physical and behavioral signs of burnout
20:55 Steps the health care industry can take against burnout

Burnout among clinicians has impacted the health care workforce to a severity nearly unmatched by any other industry in the US. To make matters worse, the exponentially increasing rate of physician shortages and systemwide exacerbations derived by the COVID-19 pandemic and the federal response to it has further strained the modern caregiver in 2024.

In short, it is significantly more difficult to work as a physician while maintaining good mental health today—and it may only get harder.

Lungcast returns in 2024 with a guest interview on the critical details of physician burnout—what drives it, how it manifests, what are its effects, and how it may be curbed.

Lungcast is a monthly respiratory news podcast series hosted by Al Rizzo, MD, chief medical officer of the American Lung Association (ALA), and produced by HCPLive.

Joining Rizzo this month is Sue Padernacht, EDd, PCC, a professional certified coach with expertise in leadership assessment, CEO and founder of Ncline Leadership Strategies, and ALA National Board Director. A unique guest relative to Lungcast’s lineup of leading clinicians and clinical researchers, Padernacht provides a deeply analytical perspective on the key details that comprise physician burnout.

Subscribe to Lungcast on Spotify here or listen to the latest episode below:

Related Videos
Leesha Ellis-Cox: Steps to Closing the Bipolar Disorder Diagnosis Gap for Blacks
Daniel Greer, PharmD: Reduction in Rehospitalizations with Antipsychotic Injections for Schizophrenia
Understanding the Link Between Substance Use and Psychiatric Symptoms, with Randi Schuster, PhD
Andrew Miller, PhD: Inventor of KarXT Discusses Pivotal EMERGENT-2 Data
New Drug Application for MDMA-Assisted Therapy for PTSD Awaits FDA Approval
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
© 2024 MJH Life Sciences

All rights reserved.